cbdMD, Inc. To Host Conference Call to Discuss September 30, 2024 Fourth Quarter and Fiscal Year 2024 Results
cbdMD (NYSE American: YCBD) has scheduled a conference call to discuss its fourth quarter and fiscal year 2024 financial results and business progress. The call will take place on Tuesday, December 17, 2024, at 4:20 p.m. Eastern Time. Investors can access the call through USA/Canada (844-763-8274) or International (647-484-8814) numbers. A replay will be available with passcode 4840580, and a webcast replay will be accessible through January 17, 2026.
cbdMD (NYSE American: YCBD) ha programmato una conferenza telefonica per discutere i risultati finanziari e i progressi aziendali del quarto trimestre e dell'esercizio fiscale 2024. La chiamata si svolgerà martedì 17 dicembre 2024, alle 16:20 ora orientale. Gli investitori possono accedere alla chiamata tramite i numeri USA/Canada (844-763-8274) o Internazionali (647-484-8814). Una registrazione sarà disponibile con il codice di accesso 4840580, e una registrazione in webcast sarà accessibile fino al 17 gennaio 2026.
cbdMD (NYSE American: YCBD) ha programado una conferencia telefónica para discutir sus resultados financieros del cuarto trimestre y del año fiscal 2024 y los avances en el negocio. La llamada tendrá lugar el martes 17 de diciembre de 2024, a las 4:20 p.m. hora del Este. Los inversores pueden acceder a la llamada a través de los números de EE.UU./Canadá (844-763-8274) o Internacionales (647-484-8814). Se dispondrá de una repetición con el código de acceso 4840580, y una repetición por webcast estará accesible hasta el 17 de enero de 2026.
cbdMD (NYSE American: YCBD)는 2024 회계연도 4분기 재무 결과 및 사업 진행 상황을 논의하기 위해 컨퍼런스 콜을 예정하고 있습니다. 전화 회의는 2024년 12월 17일 화요일, 동부 표준시로 오후 4시 20분에 진행될 예정입니다. 투자자는 미국/캐나다 번호(844-763-8274) 또는 국제 번호(647-484-8814)를 통해 콜에 접속할 수 있습니다. 재생은 비밀번호 4840580으로 제공되며, 웹캐스트 재생은 2026년 1월 17일까지 접근이 가능합니다.
cbdMD (NYSE American: YCBD) a programmé une conférence téléphonique pour discuter de ses résultats financiers du quatrième trimestre et de l'exercice 2024 ainsi que de l'avancement des affaires. L'appel aura lieu le mardi 17 décembre 2024, à 16h20 heure de l'Est. Les investisseurs peuvent accéder à l'appel via les numéros USA/Canada (844-763-8274) ou Internationaux (647-484-8814). Un enregistrement sera disponible avec le code d'accès 4840580, et un enregistrement de webdiffusion sera accessible jusqu'au 17 janvier 2026.
cbdMD (NYSE American: YCBD) hat eine Telefonkonferenz angesetzt, um über die finanziellen Ergebnisse und den Geschäftsvortschritt des vierten Quartals und des Geschäftsjahres 2024 zu diskutieren. Der Anruf findet am Dienstag, den 17. Dezember 2024, um 16:20 Uhr Eastern Time statt. Investoren können den Anruf unter den Nummern USA/Kanada (844-763-8274) oder International (647-484-8814) erreichen. Eine Wiederholung wird mit dem Zugangscode 4840580 verfügbar sein, und eine Wiederholung des Webcasts wird bis zum 17. Januar 2026 zugänglich sein.
- None.
- None.
Charlotte, North Carolina--(Newsfile Corp. - December 12, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE American: YCBDpA) one of the nation's leading, highly trusted and widely recognized CBD companies, today announces that it will host a conference call at 4:20 p.m., Eastern Time, on Tuesday, December 17, 2024, to discuss the company's September 30, 2024 fourth quarter and fiscal year 2024 financial results and business progress.
CONFERENCE CALL DETAILS
| Tuesday, December 17, 2024, 4:20 p.m. Eastern Time | ||
| USA/Canada: | 844-763-8274 | |
| International: | 647-484-8814 | |
| Teleconference Replay dial in: | ||
| USA/Canada: | 855-669-9658 | |
| International: | 412-317-0088 | |
| Replay Passcode: | 4840580 | |
| Webcast/Webcast Replay link - available through January 17, 2026: https://www.gowebcasting.com/13876 | ||
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and recognized hemp-derived cannabidiol (CBD) brands with a comprehensive line of U.S. produced, THC-free1 CBD products as well as Full Spectrum and Delta 9 THC products. The cbdMD brand currently includes high-quality, premium CBD products including tinctures, gummies, topicals, capsules, sleep aids and more. The Company's Paw CBD brand includes formulated pet products including tinctures, chews and topicals in varying strengths. cbdMD also operates ATRx Labs, a line of functional mushroom supplements. To learn more about cbdMD and the complete line of products, please visit www.cbdmd.com, follow cbdMD on Instagram and Facebook or visit one of the thousands of retail outlets that carry cbdMD products.
1 THC-free is defined as below the level of detection using validated scientific analytical tools.
Contact Information:
cbdMD, Inc.
Ronan Kennedy, CEO
Phone: +1 (704) 445-3064 email: IR@cbdmd.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/233526
FAQ
When will YCBD report its Q4 and FY 2024 earnings?
How can investors access YCBD's Q4 2024 earnings call?
How long will YCBD's Q4 2024 earnings call replay be available?
What is the passcode for YCBD's Q4 2024 earnings call replay?
